These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16412490)

  • 1. Increased HIV-DNA load in CCR5-negative lymphocytes without viral phenotypic change.
    Pakarasang M; Wasi C; Suwanagool S; Chalermchockcharoenkit A; Auewarakul P
    Virology; 2006 Apr; 347(2):372-8. PubMed ID: 16412490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
    Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
    J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
    Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L
    J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of HIV-1 coreceptor tropism in clinical practise.
    Foeglein A; Walter H
    Eur J Med Res; 2007 Oct; 12(9):473-82. PubMed ID: 17933729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
    Gray L; Sterjovski J; Churchill M; Ellery P; Nasr N; Lewin SR; Crowe SM; Wesselingh SL; Cunningham AL; Gorry PR
    Virology; 2005 Jul; 337(2):384-98. PubMed ID: 15916792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.
    Lin YL; Mettling C; Portales P; Reynes J; Clot J; Corbeau P
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15590-5. PubMed ID: 12434015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry.
    Brockman MA; Tanzi GO; Walker BD; Allen TM
    J Virol Methods; 2006 Feb; 131(2):134-42. PubMed ID: 16182382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
    Arastéh K; Stocker H
    Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
    Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor.
    Saha K; Zhang J; Gupta A; Dave R; Yimen M; Zerhouni B
    Nat Med; 2001 Jan; 7(1):65-72. PubMed ID: 11135618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the env gene of two CCR5/CXCR4-independent human immunodeficiency 2 primary isolates.
    Santos-Costa Q; Parreira R; Moniz-Pereira J; Azevedo-Pereira JM
    J Med Virol; 2009 Nov; 81(11):1869-81. PubMed ID: 19774680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor.
    Zhou Y; Kurihara T; Ryseck RP; Yang Y; Ryan C; Loy J; Warr G; Bravo R
    J Immunol; 1998 Apr; 160(8):4018-25. PubMed ID: 9558111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
    Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
    Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.